Benchmark Electronics (BHE) Stock Could Be 18.2% Overvalued After Ouster And HPE Wins

Benchmark Electronics (BHE) is back in focus after expanding its manufacturing partnership with Ouster for Rev8 lidar sensors and receiving Hewlett Packard Enterprise’s 2026 Manufacturing Partner of the Year award for work on advanced AI infrastructure.

See our latest analysis for Benchmark Electronics.

Benchmark Electronics’ recent lidar and AI manufacturing wins come on top of strong market interest, with a 30-day share price return of 13.36% and a year-to-date share price return of 109.95%, while the 1-year total shareholder return of 148.34% points to powerful, sustained momentum.

If you are tracking how AI-related hardware suppliers are being priced, it can be useful to compare Benchmark Electronics with other opportunities picked out in the Simply Wall St 49 AI infrastructure stocks

With Benchmark Electronics now trading above the current analyst price target and screeners flagging no intrinsic discount, the key question is whether recent AI and lidar wins still leave room for upside or if markets are already pricing in future growth.

Advertisement

Most Popular Narrative: 18.2% Overvalued

Benchmark Electronics last closed at $92.17, compared with a most followed narrative fair value of $78, which frames the recent share price surge in a very different light.

The analysts have a consensus price target of $78.0 for Benchmark Electronics based on their expectations of its future earnings growth, profit margins and other risk factors.

However, there is a degree of disagreement amongst analysts, with the most bullish reporting a price target of $92.0, and the most bearish reporting a price target of just $62.0.

Read the complete narrative.

Want to understand why this narrative still supports a lower fair value despite strong AI headlines and rapid earnings growth forecasts? The key is how analysts balance expected revenue expansion, margin improvement and the future earnings multiple used to discount cash flows at a 9.12% rate. Curious which assumptions carry the most weight in getting to that $78 figure instead of today’s price?

Result: Fair Value of $78 (OVERVALUED)

Have a read of the narrative in full and understand what's behind the forecasts.

However, Benchmark Electronics still faces risks if semi-cap demand remains weak or if AI data center projects scale more slowly than analysts currently factor into their models.

Find out about the key risks to this Benchmark Electronics narrative.

Next Steps

If this mix of optimism and caution around Benchmark Electronics leaves you unsure, it makes sense to review the underlying data now and weigh both sides using the 1 key reward and 2 important warning signs.

Looking for more investment ideas beyond Benchmark Electronics?

If Benchmark Electronics has sharpened your focus on quality opportunities, do not stop here. Broaden your watchlist with a few data driven ideas that other investors are already checking daily.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

Valuation is complex, but we're here to simplify it.

Discover if Benchmark Electronics might be undervalued or overvalued with our detailed analysis, featuring fair value estimates, potential risks, dividends, insider trades, and its financial condition.

Access Free Analysis

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com

About NYSE:BHE

Benchmark Electronics

Offers product design, engineering services, technology solutions, and manufacturing services in the Americas, Asia, and Europe.

Excellent balance sheet with moderate growth potential.

Advertisement

Weekly Picks

LO
Lou_Basenese
OPTH logo
Lou_Basenese on Optimi Health ·

The Only Psychedelic Company Already Selling MDMA and Psilocybin to Real Patients, Yet Priced Like It Doesn’t Exist

Fair Value:US$1157.5% undervalued
47 users have followed this narrative
2 users have commented on this narrative
8 users have liked this narrative
WE
WealthAP
NOVO B logo
WealthAP on Novo Nordisk ·

Novo Nordisk (NVO): Is the "Easy Growth" Story Over?

Fair Value:DKK 407.7721.4% undervalued
69 users have followed this narrative
0 users have commented on this narrative
8 users have liked this narrative
VA
ValueInvestingSubstack
ZTS logo
ValueInvestingSubstack on Zoetis ·

Zoetis down -50% over the past year

Fair Value:US$92.9218.9% undervalued
23 users have followed this narrative
0 users have commented on this narrative
9 users have liked this narrative
CE
CentryResearch
LEU logo
CentryResearch on Centrus Energy ·

Centrus Energy: The Next Nuclear Bottleneck Isn't Reactors. It's Fuel.

Fair Value:US$19013.7% undervalued
24 users have followed this narrative
0 users have commented on this narrative
10 users have liked this narrative

Updated Narratives

WI
WisetoWealth
PYPL logo
WisetoWealth on PayPal Holdings ·

The Underrated Transformation of a Digital Payments Giant

Fair Value:US$90.3137.8% undervalued
2 users have followed this narrative
0 users have commented on this narrative
0 users have liked this narrative
BL
Blagget
TERA logo
Blagget on Terra Balcanica Resources ·

The C$4M Explorer Positioned to Become Europe's First Antimony Mine

Fair Value:CA$0.487.5% undervalued
2 users have followed this narrative
0 users have commented on this narrative
0 users have liked this narrative
DA
CHTR logo
david_6nroa on Charter Communications ·

Charter is undervalued - Here's why.

Fair Value:US$87.0741.6% overvalued
1 users have followed this narrative
0 users have commented on this narrative
0 users have liked this narrative

Popular Narratives

CU
MSFT logo
CubanEros on Microsoft ·

A wonderful business at reasonable price.

Fair Value:US$419.919.1% undervalued
81 users have followed this narrative
0 users have commented on this narrative
6 users have liked this narrative
OS
oscargarcia
NVDA logo
oscargarcia on NVIDIA ·

The company that went from selling GPUs to gamers to becoming the AI arms dealer of the 21st century.

Fair Value:US$28026.1% undervalued
186 users have followed this narrative
9 users have commented on this narrative
15 users have liked this narrative
BE
PYPL logo
benjamin_lvieq on PayPal Holdings ·

PayPal: PayPal Doesn't Need to Grow – It Needs to Stop Falling – A Mispriced Cash Machine With a Cannibal Buyback

Fair Value:US$6513.6% undervalued
72 users have followed this narrative
2 users have commented on this narrative
11 users have liked this narrative

Trending Discussion

DE
TDOC logo
derek_3wsdg on Teladoc Health ·

You’ve overlooked the activist investor factor. Travis Cocke’s Voss has announced 5% ownership through a 13G filing. They’ve added to that 5% since, and in doing so, have created a structural trap door for 27.42 Million Shares actively sold short. Chuck will announce lots of positives on July 29 but it’s what Voss announces shortly after that will rock the overextended Teledoc shorts. The Walmart partnership is the tip of the iceberg. The market is missing the sheer regulatory and enterprise friction of modern corporate healthcare. Teladoc isn't a "consumer app"; it is the primary digital infrastructure integrated directly into the legacy backends of Tier-1 insurance companies and fortune 500 employers, covering 105 million+ lives. Teladoc is acting as the digital top-of-funnel engine for the world's largest retailer. If Voss pushes the narrative that Teladoc is effectively the outsourced digital brain of Walmart's entire healthcare footprint, the fair value shifts from a basic health multiple to an enterprise distribution premium. Additionally , we are in a structural gold rush for high-quality, legally compliant, longitudinal medical data to train vertical healthcare AI models. Large technology hyperscalers and pharmaceutical giants cannot simply scrape the internet for this; they need structured clinical inputs. Teladoc sits on one of the largest de-identified virtual medical datasets on earth. From the activist playbook , we’ll see Voss demand the immediate creation of a Data & Diagnostics Licensing Division, transforming a legacy liability into an incredibly high-margin, pure-software data asset that requires zero human clinician hours to scale. Chuck is doing great work and deserves credi5 for the Teledoc turnaround but it will be Travis Cocke who will be responsible for a share price way beyond your $15 valuation.

1
|
0